How private clinics fit into the UK cannabis prescribing system
Cannabis based medicines became legal for specialist prescription in the UK in 2018. However, access through the NHS remains limited, which has led many patients to explore treatment through private healthcare services.
Understanding how private clinics fit into the wider prescribing system can help explain how patients access cannabis based medicines in the UK today.
The Legal Framework
UK law allows cannabis based medicines to be prescribed by doctors listed on the General Medical Council specialist register. These medicines remain tightly regulated and are usually considered only when other treatments have not provided sufficient benefit.
Prescriptions must be issued by a qualified specialist and medicines are dispensed through licensed pharmacies.
This regulatory framework applies to both NHS and private healthcare settings.
Limited NHS Prescribing
Although prescribing is legally permitted, NHS access is currently restricted. National clinical guidelines recommend cannabis based medicines in a limited number of situations, such as certain forms of treatment resistant epilepsy, chemotherapy related nausea, and spasticity associated with multiple sclerosis.
Because of these restrictions, many NHS clinicians do not routinely prescribe cannabis based medicines outside of these indications.
The Role of Private Clinics
Private clinics operate within the same legal framework but may provide consultations specifically focused on assessing whether cannabis based treatment may be appropriate.
These clinics allow patients to speak with specialist doctors who have experience reviewing complex cases where conventional treatments may not have been effective.
During a consultation, the clinician typically reviews the patient’s medical history, previous treatments, and current symptoms before considering whether cannabis based medicine may be suitable.
Clinical Oversight and Monitoring
If treatment is prescribed, medicines are supplied through regulated pharmacies and patients are usually reviewed regularly.
Follow up appointments allow clinicians to monitor progress, assess any side effects, and adjust treatment if necessary.
This type of ongoing review is an important part of responsible prescribing.
Access Through Specialist Services
Clinics such as Keltoi Clinic provide consultations where clinicians assess medical history, discuss symptoms, and determine whether cannabis based treatment may be appropriate.
Where prescriptions are issued, medicines are dispensed through licensed UK pharmacies in line with regulatory requirements.
Conclusion
Private clinics play a role in the UK cannabis prescribing system by providing specialist consultations within the existing regulatory framework. They allow patients to discuss treatment options with qualified clinicians while ensuring that prescribing decisions remain subject to appropriate clinical assessment and oversight.
Information provided for general guidance only. Individual suitability is assessed by a clinician.